These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37443554)

  • 1. Self-Reported Systemic Sclerosis-Related Symptoms Are More Prevalent in Subjects with Raynaud's Phenomenon in the Lifelines Population: Focus on Pulmonary Complications.
    van de Zande SC; Abdulle AE; Al-Adwi Y; Stel A; de Leeuw K; Brouwer E; Arends S; Gan CT; van Goor H; Mulder DJ
    Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical relevance of Raynaud's phenomenon symptom characteristics in systemic sclerosis.
    Hughes M; Huang S; Pauling JD; Sabbagh M; Khanna D
    Clin Rheumatol; 2022 Oct; 41(10):3049-3054. PubMed ID: 35583625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis.
    Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ;
    Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raynaud's phenomenon-an update on diagnosis, classification and management.
    Pauling JD; Hughes M; Pope JE
    Clin Rheumatol; 2019 Dec; 38(12):3317-3330. PubMed ID: 31420815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity.
    Pauling JD; Reilly E; Smith T; Frech TM
    Arthritis Care Res (Hoboken); 2019 Aug; 71(8):1119-1126. PubMed ID: 30133174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of Scleroderma pattern at nail fold capillaroscopy valuable in the exclusion of Scleroderma in unselected patients with Raynaud's Phenomenon.
    Bissell LA; Abignano G; Emery P; Del Galdo F; Buch MH
    BMC Musculoskelet Disord; 2016 Aug; 17(1):342. PubMed ID: 27526772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of progression to systemic sclerosis: analysis of very early diagnosis of systemic sclerosis in a large single-centre cohort.
    Siqueira VS; Helbingen MFS; Medeiros-Ribeiro AC; Carriço da Silva H; Miossi R; Luppino-Assad AP; Sampaio-Barros PD
    Rheumatology (Oxford); 2022 Aug; 61(9):3686-3692. PubMed ID: 35020814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship between Smoking, Raynaud's Phenomenon, Digital Ulcers, and Skin Thickness in the Waikato Systemic Sclerosis Cohort.
    Silva C; Solanki KK; White DHN
    Rheumatol Immunol Res; 2022 Jun; 3(2):84-89. PubMed ID: 36465326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report.
    Pauling JD; Frech TM; Hughes M; Gordon JK; Domsic RT; Anderson ME; Ingegnoli F; McHugh NJ; Johnson SR; Hudson M; Boin F; Ong VH; Matucci-Cerinic M; Altorok N; Scolnik M; Nikpour M; Shah A; Pope JE; Khanna D; Herrick AL
    J Scleroderma Relat Disord; 2018 Oct; 3(3):249-252. PubMed ID: 30705970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of internet-based information for individuals with Raynaud's phenomenon and patients with systemic sclerosis.
    Devgire V; Martin AF; McKenzie L; Sandler RD; Hughes M
    Clin Rheumatol; 2020 Aug; 39(8):2363-2367. PubMed ID: 32152916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.
    Motegi S; Yamada K; Toki S; Uchiyama A; Kubota Y; Nakamura T; Ishikawa O
    J Dermatol; 2016 Jan; 43(1):56-62. PubMed ID: 26173902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis.
    Pauling JD; Domsic RT; Saketkoo LA; Almeida C; Withey J; Jay H; Frech TM; Ingegnoli F; Dures E; Robson J; McHugh NJ; Herrick AL; Matucci-Cerinic M; Khanna D; Hewlett S
    Arthritis Care Res (Hoboken); 2018 Sep; 70(9):1373-1384. PubMed ID: 29473715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of botulinum toxin type A injection for Raynaud's phenomenon and digital ulcers in patients with systemic sclerosis.
    Jokar MH; Baghbani B; Geraylow KR; Shariati J; Mehrad-Majd H; Mirfeizi Z; Hashemzadeh K
    Reumatologia; 2022; 60(6):392-398. PubMed ID: 36683833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raynaud's phenomenon.
    Herrick AL; Wigley FM
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101474. PubMed ID: 32007400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
    Pamuk GE; Turgut B; Pamuk ON; Vural O; Demir M; Cakir N
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):297-302. PubMed ID: 17473568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Influencing Patient Decision-Making Concerning Treatment Escalation in Raynaud's Phenomenon Secondary to Systemic Sclerosis.
    Hughes M; Huang S; Pauling JD; Sabbagh M; Khanna D
    Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1845-1852. PubMed ID: 34057304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Audiovestibular Manifestations in Patients with Primary Raynaud's Phenomenon and Raynaud's Phenomenon Secondary to Systemic Sclerosis.
    Amor-Dorado JC; Martín-Sanz E; Franco-Gutiérrez V; Urruticoechea-Arana A; García-Arumí AM; Racines-Álava E; Alemán-López O; Simeón-Aznar CP; González-Gay MÁ
    J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing recovery after cold challenge and thumb involvement can help to rule out systemic sclerosis in patients presenting with Raynaud's phenomenon.
    van Roon AM; van Roon AM; Stel AJ; Bootsma H; Smit AJ; Mulder DJ
    Scand J Rheumatol; 2020 Mar; 49(2):137-140. PubMed ID: 31637927
    [No Abstract]   [Full Text] [Related]  

  • 20. Raynaud's phenomenon.
    Hughes M; Herrick AL
    Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):112-32. PubMed ID: 27421220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.